Tyloxapol inhibits NF-κB and cytokine release, scavenges HOCl, and reduces viscosity of cystic fibrosis sputum

Andrew J. Ghio, Bruce C. Marshall, Jose L. Diaz, Takashi Hasegawa, Wayne Samuelson, Daniel Povia, Thomas P. Kennedy, Claude A. Piantadosi

Research output: Contribution to journalArticle

Fingerprint Dive into the research topics of 'Tyloxapol inhibits NF-κB and cytokine release, scavenges HOCl, and reduces viscosity of cystic fibrosis sputum'. Together they form a unique fingerprint.

Medicine & Life Sciences